WHO 2024 Hepatitis B Guidelines and Treatment-Eligible Rate Among Treatment-Naive Patients

被引：0
|
作者：
Wang, Jian [1 ,2 ]
Zhang, Shaoqiu [1 ]
Zhu, Chuanwu [3 ]
Wu, Chao [1 ,2 ]
Huang, Rui [1 ,2 ]
机构：
[1] Nanjing Univ, Nanjing Drum Tower Hosp, Affiliated Hosp, Med Sch,Dept Infect Dis, 321 Zhongshan Rd, Nanjing 210008, Jiangsu, Peoples R China
[2] Nanjing Univ, Inst Viruses & Infect Dis, Nanjing, Jiangsu, Peoples R China
[3] Soochow Univ, Affiliated Infect Dis Hosp, Dept Infect Dis, Suzhou, Jiangsu, Peoples R China
来源：
JAMA NETWORK OPEN | 2024年 / 7卷 / 09期
关键词：
D O I：
10.1001/jamanetworkopen.2024.35777
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
This cross-sectional study compares rates of hepatitis B treatment eligibility among treatment-naive patients according to the World Health Organization (WHO) 2024 guidelines with eligibility rates across other international guidelines.
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Autonomic impairment in treatment-naive patients with chronic hepatitis B and C infections
    Huang, Chih-Cheng
    Wu, Keng-Liang
    Liu, Jia-Shou
    Chang, Yung-Yee
    AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL, 2022, 238
  • [22] Prevalence of hepatitis B virus DNA polymerase mutations in treatment-naive patients with chronic hepatitis B
    Nguyen, M. H.
    Garcia, R. T.
    Trinh, H. N.
    Nguyen, H. A.
    Nguyen, K. K.
    Nguyen, L. H.
    Levitt, B.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2009, 30 (11-12) : 1150 - 1158
  • [23] Overt and occult hepatitis B virus infection among treatment-naive HIV-infected patients in Brazil
    Oliveira, Marina Pedroso
    Lemes, Pollyanne Sousa
    Dias Matos, Marcia Alves
    Alves Del-Rios, Nativa Helena
    Santos Carneiro, Megmar Aparecida
    Costa Silva, Agabo Macedo
    Rodrigues Lopes, Carmen Luci
    Teles, Sheila Araujo
    Aires, Rodrigo Sebba
    Lago, Barbara Vieira
    Araujo, Natalia Motta
    Bringel Martins, Regina Maria
    JOURNAL OF MEDICAL VIROLOGY, 2016, 88 (07) : 1222 - 1229
  • [24] Long-term Follow-up and Treatment Rates of Treatment-Eligible Chronic Hepatitis B (CHB) Patients: A Multicenter Cohort Study
    Vu, Vinh D.
    Do, Ailinh
    Nguyen, Nghia H.
    Kim, Lily H.
    Trinh, Huy N.
    Nguyen, Huy A.
    Nguyen, Khanh
    Nguyen, Mindie H.
    HEPATOLOGY, 2014, 60 : 1125A - 1126A
  • [25] Genotyping of HBV and tracking of resistance mutations in treatment-naive patients with chronic hepatitis B
    Pacheco, Sidelcina Rugieri
    Magalhaes Andrade dos Santos, Maria Isabel
    Stocker, Andreas
    Sant'Anna Zarife, Maria Alice
    Schinoni, Maria Isabel
    Parana, Raymundo
    dos Reis, Mitermayer Galvao
    Silva, Luciano Kalabric
    INFECTION AND DRUG RESISTANCE, 2017, 10 : 201 - 207
  • [26] Potential antiviral drug resistance mutations in patients with treatment-naive chronic hepatitis B
    Cakal, Bulent
    Cavus, Bilger
    Poda, Mehves
    Atasoy, Alp
    Bulakci, Mesut
    Gulluoglu, Mine
    Akyuz, Filiz
    ANNALS OF CLINICAL AND ANALYTICAL MEDICINE, 2024, 15 (03): : 182 - 187
  • [27] Letter: tenofovir may be superior to entecavir for treatment-naive chronic hepatitis B patients
    Wang, Ji-Gan
    Chen, Rui
    Wang, Li-Chuan
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 53 (09) : 1048 - 1049
  • [28] Prevalence of occult hepatitis B infection among treatment-naive persons living with HIV in Ghana
    Salia, Emmanuel
    Nartey, Yvonne Ayerki
    Djankpa, Francis Tanam
    Pappoe, Faustina
    Nuvor, Samuel Victor
    Obiri-Yeboah, Dorcas
    PLOS ONE, 2024, 19 (06):
  • [29] OUTCOME OF 4-YEAR TREATMENT OF ENTECAVIR FOR TREATMENT-NAIVE CHRONIC HEPATITIS B
    Seto, W-K.
    Lai, C-L.
    Fung, J.
    Yuen, J. C-H.
    Wong, D. K-H.
    Yuen, M-F.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S301 - S301
  • [30] THE COMPARISON OF 24 WEEKS TREATMENT EFFICACY BETWEEN ENTECAVIR AND CLEVUDINE IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HEPATITIS B
    Sul, Hye Ryoung
    Kim, Hyung Joon
    Lee, Hyun Woong
    Kim, Sung Jin
    Chung, Sun Joo
    Hwang, Seung Jae
    Choi, Chang Hwan
    Kim, Jung Uk
    Do, Jae Hyuk
    Chang, Sae Kyung
    Park, Sill Moo
    HEPATOLOGY, 2008, 48 (04) : 715A - 715A
12345